Kymera Therapeutics, Inc. 2026 Q1 – Outcomes – Earnings Name Presentation (NASDAQ:KYMR) 2026-05-04
Q1: 2026-04-30 Earnings Abstract
EPS of -$0.71 beats by $0.15
| Income of $34.37M (55.50% Y/Y) beats by $26.14M
In search of Alpha’s transcripts crew is chargeable for the event of all of our transcript-related tasks. We at the moment publish hundreds of quarterly earnings calls per quarter on our web site and are persevering with to develop and increase our protection. The aim of this profile is to permit us to share with our readers new transcript-related developments. Thanks, SA Transcripts Crew
